FMR CORP 13D/13G Filings for Acorda Therapeutics, Inc. (ACOR)

FMR CORP 13D and 13G filings for Acorda Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-08-10
09:25 am
Sale		 2020-08-07 13G Acorda Therapeutics, Inc.
ACOR		 FMR CORP 460
0.114%		 -23,880decrease
(-98.11%)		 Filing
2020-06-10
10:13 am
Sale		 2020-06-09 13G Acorda Therapeutics, Inc.
ACOR		 FMR CORP 24,340
6.080%		 -29,245decrease
(-54.58%)		 Filing